RxDoctor Payments Data

Richard Giaccio, MD

Psychiatry · Syracuse, NYNPI 1659413045

Payments from drug & device makers

$2,512in general payments, 2019–2025

Across 122 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$582
  • Alkermes, Inc.$446
  • Teva Pharmaceuticals USA, Inc.$337
  • Otsuka America Pharmaceutical, Inc.$336
  • Neurocrine Biosciences, Inc.$241
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$238
  • plus $332 from 6 others

What the payments were for

  • Food & beverage$2,46398%
  • Education$492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,512 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$14,709
Medicare patients
23
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine25$126,129
Invega TrinzaPaliperidone Palmitate16$99,019
AuvelityDextromethorphan Hbr/Bupropion43$51,545
TrintellixVortioxetine Hydrobromide15$10,154
Clozapine66$9,730
Aripiprazole37$4,385
Mirtazapine70$2,456
Duloxetine Hcl112$2,340
Lurasidone Hcl42$2,168
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine63$1,751
Hydroxyzine Hcl96$1,725
Clonazepam71$1,594
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine43$1,424
Topiramate82$1,418
Methylphenidate ErMethylphenidate Hcl19$1,315

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$337$126,12925 claims
Johnson & JohnsonInvega Trinza$582$99,01916 claims
Axsome Therapeutics, Inc.Auvelity$64$51,54543 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$79$10,15415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →